Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-12-14A Multicenter Randomized Controlled Trial of the Efficacy and Safety of PEG-rhG-CSF Compared With rhG-CSF After Autologous Hematopoietic Stem Cell Transplantation for Lymphoma Patients
-
CLINICAL_TRIALS study record update · 2021-12-13A Phase 1-2 Study to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Mantle Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2021-12-01Phase II Trial of Response-Adapted Therapy Based on Positron Emission Tomography (PET) for Bulky Stage I and Stage II Classical Hodgkin Lymphoma (HL)
-
CLINICAL_TRIALS study record update · 2021-11-12Safety and Efficiency Study of ET019003-T Cells in Relapsed/Refractory CD19+ B-Cell Leukemia and Lymphoma
-
CLINICAL_TRIALS study record update · 2021-11-12A Phase I, Multiple Center, Open-label, Dose Escalation and Dose Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2021-11-03Haploidentical Donor Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-10-27Phase II Trial of EPOCH and Rituxan Combined Therapy in Patients With Refractory or Relapsed CD20 Positive Intermediate Grade B-cell Non-Hodgkin's Lymphoma
-
CLINICAL_TRIALS study record update · 2021-10-15Total-body 18F-FDG PET / CT in the Evaluation of Treatment and Prognosis of Patients With Lymphoma
-
CLINICAL_TRIALS study record update · 2021-10-13Diagnosis of Lymphoma Using Endobronchial Ultrasound Guided Miniforceps Biopsy.
-
CLINICAL_TRIALS study record update · 2021-10-12A Phase 1, Open-Label, Multicenter Trial Investigating the Safety, Tolerability, and Preliminary Antineoplastic Activity of Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
-
CLINICAL_TRIALS study record update · 2021-10-11Phase 1 Study of ACTR707, an Autologous T Cell Product, in Combination With Rituximab, in Subjects With Relapsed or Refractory CD20+ B Cell Lymphoma
-
CLINICAL_TRIALS study record update · 2021-10-11Phase 1 Study of Nivolumab in Combination With Tocilizumab for Treatment of Patients With Relapsed Hematological Malignancies Post-allogeneic Transplant
-
CLINICAL_TRIALS study record update · 2021-10-08Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autologous Hematopoietic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2021-10-01Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia- A Retrospective Study
-
CLINICAL_TRIALS study record update · 2021-09-30A Multi-Centre, Randomized Controlled Trial of Self-Management and Activation to Reduce Treatment-Related Toxicities in Patients Receiving Adjuvant or First-Line Metastatic Oral or Systematic Therapy for Colorectal, Lymphoma or Lung Cancer (SMARTCare)
-
CLINICAL_TRIALS study record update · 2021-09-29Establishment of GlucoCEST MRI as a Biomarker in Cancer Translational Study
-
CLINICAL_TRIALS study record update · 2021-09-24A Phase Ⅰ/Ⅱ Study to Evaluate the Safety, Tolerance, Pharmacokinetics and Efficacy of SYHX1903 in Patients With Relapsed/Refractory Hematologic Malignancies
-
CLINICAL_TRIALS study record update · 2021-09-21Phase 1/2 Study of AMG 531 to Evaluate the Safety, Efficacy, and Pharmacokinetics in Patients With Aggressive Non-Hodgkin's Lymphoma Receiving R-HyperCVAD Alternating With R-Ara-C/MTX
-
CLINICAL_TRIALS study record update · 2021-09-21Banking DNA for Analysis of Genetic Polymorphisms in Patients With Cancer
-
CLINICAL_TRIALS study record update · 2021-09-08A Pharmacokinetic Study of Pemetrexed in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
-
CLINICAL_TRIALS study record update · 2021-09-05Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)
-
CLINICAL_TRIALS study record update · 2021-08-25A Phase II Study of 10-Propargyl-10-Deazaaminopterin (PDX) in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphomas and Hodgkin's Disease
-
CLINICAL_TRIALS study record update · 2021-08-17CMV-MVA Triplex Vaccine to Enhance Adaptive NK Cell Reconstitution After Autologous Hematopoietic Cell Transplantation in Patients With Lymphoid Malignancies
-
CLINICAL_TRIALS study record update · 2021-08-16The Capability of Haemato-oncology Patients to Generate Antibodies Against COVID-19 After Infection and Vaccination
-
CLINICAL_TRIALS study record update · 2021-08-16With Open, Single/Multiple Dosing and Dose Escalation, Phase I Clinical Trial Scheme to Evaluate Safety, Tolerance and Pharmacokinetic Properties of Genolimzumab Injection